Verastem Oncology to Present at Three Investor Conferences
Verastem Oncology management is scheduled to present at three healthcare investor conferences.
Related stories
IDEXX Executive Says Covet Revenue Run Rate Is About $20 Million
An IDEXX executive said Covet revenue is growing at strong double-digit rates.
M impact | EQUITY | Nov 02, 2026, 01:46 PM UTC
Infineon and Qualcomm Technologies Sign Automated Driving Agreement
M impact | EQUITY | Nov 02, 2026, 01:46 PM UTC
Fox Shares Rise After Q1 Results Top Estimates
Fox shares rise after first-quarter results top estimates, supported by advertising.
M impact | EQUITY | Nov 02, 2026, 01:45 PM UTC
AAR Proposes $955 Million and $960 Million Senior Note Offerings
AAR proposed $955 million of senior notes due 2031 and $960 million of senior notes due 2034.
M impact | EQUITY | Nov 02, 2026, 01:45 PM UTC
Teva shares fall after rare brain disorder drug trial halted
US-listed shares of Israel-based Teva fell after a trial of a drug for a rare brain disorder was halted.
M impact | EQUITY | Nov 02, 2026, 01:45 PM UTC
Fox Q1 results beat on advertising strength
Fox shares rose after the company reported Q1 results that beat expectations, citing advertising strength.
M impact | EQUITY | Nov 02, 2026, 01:45 PM UTC